@jgfellow-nephro.bsky.social
Reposted
Let me know if the link that I sent worked. If not I can walk you through how I found it.
November 27, 2025 at 11:37 PM
Let me know if the link that I sent worked. If not I can walk you through how I found it.
I don’t think it matters if they are a DO or MD. They have the same training now. There are bad MDs (look at Casey Means) and DOs and there are great MDs and DOs.
October 11, 2025 at 3:48 PM
I don’t think it matters if they are a DO or MD. They have the same training now. There are bad MDs (look at Casey Means) and DOs and there are great MDs and DOs.
Reposted
Paired nicely with the French ALCHEMIST trial (also negative)
www.thelancet.com/journals/lan...
#NephJC #NephSky
www.thelancet.com/journals/lan...
#NephJC #NephSky
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-anal...
In patients with kidney failure on haemodialysis and with high risk of adverse cardiovascular
outcomes, spironolactone did not reduce the incidence of major cardiovascular events.
The updated meta-ana...
www.thelancet.com
August 15, 2025 at 1:59 AM
Paired nicely with the French ALCHEMIST trial (also negative)
www.thelancet.com/journals/lan...
#NephJC #NephSky
www.thelancet.com/journals/lan...
#NephJC #NephSky